Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S (NOVO B)
Mes derničres consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novo Nordisk A/S
Develops, manufactures, markets and distributes pharmaceutical products

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products.

It operates through the following business segments: Diabetes & Obesity Care, and Biopharmaceuticals.

The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity.

The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy.

The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsvćrd, Denmark.

Number of employees : 42 076 persons.
Sales per Businesses
20162017Delta
DKK (in Million)%DKK (in Million)%
Diabetes Care and Obesity88,94979.6%92,87783.2% +4.42%
Biopharmaceuticals22,83120.4%18,81916.8% -17.57%
Sales per Regions
20162017Delta
DKK (in Million)%DKK (in Million)%
United States57,19451.2%55,83150% -2.38%
Europe20,68218.5%21,18919% +2.45%
International14,05012.6%---
China10,4589.4%10,7099.6% +2.4%
Pacific9,3968.4%---
Africa, Asia, Middle East & Oceania--12,01810.8%-
Japan & Korea--6,0725.4%-
Latin America--3,6993.3%-
Canada--2,1781.9%-
Managers
NameAgeSinceTitle
Lars Fruergaard Jřrgensen, MBA521991President & Chief Executive Officer
Göran Ando692005Chairman
Maziar Mike Doustdar481992Executive Vice President-International Operations
Karsten Munk Knudsen46-Chief Financial Officer
Mads Krogsgaard Thomsen, PhD581991Chief Science Officer & Executive Vice President
Anne Marie Handrup Kverneland621981Director
Stig Strřbćk541992Director
Elizabeth Anne Hewitt622012Independent Director
Sřren Thuesen Pedersen, MBA541994Director
Jeppe Fonager Christiansen592013Vice Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,962,564,000 1,753,082,748 89.3% 56,000,000 2.9% 70.1%
Share B 10 537,436,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Novo Nordisk Fonden 160,726,590 8.19%
Novo Nordisk A/S 63,717,504 3.25%
The Vanguard Group, Inc. 44,284,013 2.26%
Norges Bank Investment Management 42,958,316 2.19%
Alecta Pension Insurance Mutual 28,698,000 1.46%
BlackRock Fund Advisors 20,719,894 1.06%
Capital Research & Management Co. (World Investors) 19,704,685 1.00%
Jupiter Asset Management Ltd. 18,220,714 0.93%
Flossbach von Storch AG 18,016,800 0.92%
Fundsmith LLP 13,295,158 0.68%
Holdings
NameEquities%Valuation
Novo Nordisk A/S (NOVO B) 63,717,5043.25%3,555,859,170 USD
Nnit A/S (NNIT) 4,375,00017.5%134,746,063 USD
Innate Pharma (IPH) 8,908,45615.5%64,644,122 USD
Affimed NV (AFMD) 2,663,8305.96%3,529,575 USD
Pieris Pharmaceuticals Inc (PIRS) 0
Company contact information
Novo Nordisk A/S
Novo Allé
Bagsvćrd, Capital Region 2880

Phone : +45.44.44.88.88
Web : www.novonordisk.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVO NORDISK A/S-4.17%103 898
JOHNSON & JOHNSON-7.02%349 006
NOVARTIS-2.94%222 939
PFIZER-1.33%213 155
ROCHE HOLDING LTD.-9.41%207 036
MERCK AND COMPANY-3.02%148 618
AMGEN4.92%132 428
BRISTOL-MYERS SQUIBB COMPANY7.60%108 890
ABBOTT LABORATORIES3.36%102 678
SANOFI-9.46%100 767
BAYER-5.85%100 069
GLAXOSMITHKLINE-2.00%91 716
ELI LILLY AND COMPANY-8.61%85 390
ASTRAZENECA-7.21%84 103
CELGENE CORPORATION-10.14%70 622
ALLERGAN PLC-2.56%53 014
TAKEDA PHARMACEUTICAL CO LTD-8.37%43 574
SHIRE-22.46%38 453
JIANGSU HENGRUI MEDICINE CO LTD5.06%32 416
ASTELLAS PHARMA INC5.38%29 217
CHUGAI PHARMACEUTICAL CO LTD-6.59%28 495
Connections : Novo Nordisk A/S
Melrose Holdings Ltd.
Fondsmćglerselskabet Maj Invest A/S (Broker)
Archimedes Pharma UK Ltd.
HOFOR Forsyning Holding A/S
Harno Invest A/S
Bio*One Capital Pte Ltd.
Silverwood Property Ltd.
EUSA Pharma (Europe) Ltd.
Hofor Forsyning A/S
RAND Health
EUSA Pharma (UK) Ltd.
The International Centre for Missing & Exploited Children
SWMF Life Science Venture Fund LP
NNE Pharmaplan A/S
Essex Woodlands Health Ventures UK Ltd.
Maj Invest Holding A/S
Hofor Forsyning Komplementar A/S
Fondsmćglerselskabet Maj Invest A/S
Steno Diabetes Center A/S
Haldor Topsoe A/S
University of Copenhagen
Novo Nordisk Fonden
SC Triton Industry SRL
© 2018 People , Fundamentals and Ownership